UK Health Agency Overstated Positive Responses To Zocor Switch – Journal
This article was originally published in The Tan Sheet
Executive Summary
MHRA "inaccurately reported" the number of positive responses it received during a consultation period to switch Merck's Zocor Heart-Pro (simvastatin 10 mg) to nonprescription status in the UK, an article published in the Drug & Therapeutics Bulletin says